Loading clinical trials...
Loading clinical trials...
a Clinical Research of Sequential CAR-T Bridging Hematopoietic Stem Cell Transplantation in the Treatment of Relapse/Refractory B-cell Malignancies
Conditions
Interventions
CD19 or CD20 CAR T cells briging HSCT
Locations
1
China
Southwest Hospital of Third Millitary Medical University
Chongqing, Chongqing Municipality, China
Start Date
July 1, 2016
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2019
Last Updated
September 7, 2016
NCT07162181
NCT06528301
NCT03293173
NCT04210219
NCT02278796
NCT03190330
Lead Sponsor
Southwest Hospital, China
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions